Redsense Medical AB (publ)
RDSNF
$0.51
-$0.54-51.43%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -156.63% | 266.13% | -636.92% | 123.03% | -183.80% |
| Total Depreciation and Amortization | -6.25% | 0.00% | 0.00% | 6.67% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 196.36% | -258.84% | 722.00% | 81.41% | 68.90% |
| Change in Net Operating Assets | 155.09% | -266.38% | 158.97% | -45,545.45% | -98.48% |
| Cash from Operations | 208.03% | -247.98% | 109.92% | -47.38% | -62.00% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -2,327.27% | -101.21% |
| Cash from Investing | -- | -- | -- | -2,400.00% | -101.21% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -23.14% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -100.00% | -21.09% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 193.03% | -108.64% | 87.89% | 232.21% | -4,420.59% |